Cargando…

N-Acetylcysteine and Allopurinol Synergistically Enhance Cardiac Adiponectin Content and Reduce Myocardial Reperfusion Injury in Diabetic Rats

BACKGROUND: Hyperglycemia-induced oxidative stress plays a central role in the development of diabetic myocardial complications. Adiponectin (APN), an adipokine with anti-diabetic and anti-ischemic effects, is decreased in diabetes. It is unknown whether or not antioxidant treatment with N-acetylcys...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tingting, Qiao, Shigang, Lei, Shaoqing, Liu, Yanan, Ng, Kwok F. J., Xu, Aimin, Lam, Karen S. L., Irwin, Michael G., Xia, Zhengyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166050/
https://www.ncbi.nlm.nih.gov/pubmed/21912612
http://dx.doi.org/10.1371/journal.pone.0023967
_version_ 1782211112300707840
author Wang, Tingting
Qiao, Shigang
Lei, Shaoqing
Liu, Yanan
Ng, Kwok F. J.
Xu, Aimin
Lam, Karen S. L.
Irwin, Michael G.
Xia, Zhengyuan
author_facet Wang, Tingting
Qiao, Shigang
Lei, Shaoqing
Liu, Yanan
Ng, Kwok F. J.
Xu, Aimin
Lam, Karen S. L.
Irwin, Michael G.
Xia, Zhengyuan
author_sort Wang, Tingting
collection PubMed
description BACKGROUND: Hyperglycemia-induced oxidative stress plays a central role in the development of diabetic myocardial complications. Adiponectin (APN), an adipokine with anti-diabetic and anti-ischemic effects, is decreased in diabetes. It is unknown whether or not antioxidant treatment with N-acetylcysteine (NAC) and/or allopurinol (ALP) can attenuate APN deficiency and myocardial ischemia reperfusion (MI/R) injury in the early stage of diabetes. METHODOLOGY/PRINCIPAL FINDINGS: Control or streptozotocin (STZ)-induced diabetic rats were either untreated (C, D) or treated with NAC (1.5 g/kg/day) or ALP (100 mg/kg/day) or their combination for four weeks starting one week after STZ injection. Plasma and cardiac biochemical parameters were measured after the completion of treatment, and the rats were subjected to MI/R by occluding the left anterior descending artery for 30 min followed by 2 h reperfusion. Plasma and cardiac APN levels were decreased in diabetic rats accompanied by decreased cardiac APN receptor 2 (AdipoR2), reduced phosphorylation of Akt, signal transducer and activator of transcription 3 (STAT3) and endothelial nitric oxide synthase (eNOS) but increased IL-6 and TNF-α (all P<0.05 vs. C). NAC but not ALP increased cardiac APN concentrations and AdipoR2 expression in diabetic rats. ALP enhanced the effects of NAC in restoring cardiac AdipoR2 and phosphorylation of Akt, STAT3 and eNOS in diabetic rats. Further, NAC and ALP, respectively, decreased postischemic myocardial infarct size and creatinine kinase-MB (CK-MB) release in diabetic rats, while their combination conferred synergistic protective effects. In addition, exposure of cultured rat cardiomyocytes to high glucose resulted in significant reduction of cardiomyocyte APN concentration and AdipoR2 protein expression. APN supplementation restored high glucose induced AdipoR2 reduction in cardiomyocytes. CONCLUSIONS/SIGNIFICANCE: NAC and ALP synergistically restore myocardial APN and AdipoR2 mediated eNOS activation. This may represent the mechanism through which NAC and ALP combination greatly reduces MI/R injury in early diabetic rats.
format Online
Article
Text
id pubmed-3166050
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-31660502011-09-12 N-Acetylcysteine and Allopurinol Synergistically Enhance Cardiac Adiponectin Content and Reduce Myocardial Reperfusion Injury in Diabetic Rats Wang, Tingting Qiao, Shigang Lei, Shaoqing Liu, Yanan Ng, Kwok F. J. Xu, Aimin Lam, Karen S. L. Irwin, Michael G. Xia, Zhengyuan PLoS One Research Article BACKGROUND: Hyperglycemia-induced oxidative stress plays a central role in the development of diabetic myocardial complications. Adiponectin (APN), an adipokine with anti-diabetic and anti-ischemic effects, is decreased in diabetes. It is unknown whether or not antioxidant treatment with N-acetylcysteine (NAC) and/or allopurinol (ALP) can attenuate APN deficiency and myocardial ischemia reperfusion (MI/R) injury in the early stage of diabetes. METHODOLOGY/PRINCIPAL FINDINGS: Control or streptozotocin (STZ)-induced diabetic rats were either untreated (C, D) or treated with NAC (1.5 g/kg/day) or ALP (100 mg/kg/day) or their combination for four weeks starting one week after STZ injection. Plasma and cardiac biochemical parameters were measured after the completion of treatment, and the rats were subjected to MI/R by occluding the left anterior descending artery for 30 min followed by 2 h reperfusion. Plasma and cardiac APN levels were decreased in diabetic rats accompanied by decreased cardiac APN receptor 2 (AdipoR2), reduced phosphorylation of Akt, signal transducer and activator of transcription 3 (STAT3) and endothelial nitric oxide synthase (eNOS) but increased IL-6 and TNF-α (all P<0.05 vs. C). NAC but not ALP increased cardiac APN concentrations and AdipoR2 expression in diabetic rats. ALP enhanced the effects of NAC in restoring cardiac AdipoR2 and phosphorylation of Akt, STAT3 and eNOS in diabetic rats. Further, NAC and ALP, respectively, decreased postischemic myocardial infarct size and creatinine kinase-MB (CK-MB) release in diabetic rats, while their combination conferred synergistic protective effects. In addition, exposure of cultured rat cardiomyocytes to high glucose resulted in significant reduction of cardiomyocyte APN concentration and AdipoR2 protein expression. APN supplementation restored high glucose induced AdipoR2 reduction in cardiomyocytes. CONCLUSIONS/SIGNIFICANCE: NAC and ALP synergistically restore myocardial APN and AdipoR2 mediated eNOS activation. This may represent the mechanism through which NAC and ALP combination greatly reduces MI/R injury in early diabetic rats. Public Library of Science 2011-08-30 /pmc/articles/PMC3166050/ /pubmed/21912612 http://dx.doi.org/10.1371/journal.pone.0023967 Text en Wang et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Wang, Tingting
Qiao, Shigang
Lei, Shaoqing
Liu, Yanan
Ng, Kwok F. J.
Xu, Aimin
Lam, Karen S. L.
Irwin, Michael G.
Xia, Zhengyuan
N-Acetylcysteine and Allopurinol Synergistically Enhance Cardiac Adiponectin Content and Reduce Myocardial Reperfusion Injury in Diabetic Rats
title N-Acetylcysteine and Allopurinol Synergistically Enhance Cardiac Adiponectin Content and Reduce Myocardial Reperfusion Injury in Diabetic Rats
title_full N-Acetylcysteine and Allopurinol Synergistically Enhance Cardiac Adiponectin Content and Reduce Myocardial Reperfusion Injury in Diabetic Rats
title_fullStr N-Acetylcysteine and Allopurinol Synergistically Enhance Cardiac Adiponectin Content and Reduce Myocardial Reperfusion Injury in Diabetic Rats
title_full_unstemmed N-Acetylcysteine and Allopurinol Synergistically Enhance Cardiac Adiponectin Content and Reduce Myocardial Reperfusion Injury in Diabetic Rats
title_short N-Acetylcysteine and Allopurinol Synergistically Enhance Cardiac Adiponectin Content and Reduce Myocardial Reperfusion Injury in Diabetic Rats
title_sort n-acetylcysteine and allopurinol synergistically enhance cardiac adiponectin content and reduce myocardial reperfusion injury in diabetic rats
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166050/
https://www.ncbi.nlm.nih.gov/pubmed/21912612
http://dx.doi.org/10.1371/journal.pone.0023967
work_keys_str_mv AT wangtingting nacetylcysteineandallopurinolsynergisticallyenhancecardiacadiponectincontentandreducemyocardialreperfusioninjuryindiabeticrats
AT qiaoshigang nacetylcysteineandallopurinolsynergisticallyenhancecardiacadiponectincontentandreducemyocardialreperfusioninjuryindiabeticrats
AT leishaoqing nacetylcysteineandallopurinolsynergisticallyenhancecardiacadiponectincontentandreducemyocardialreperfusioninjuryindiabeticrats
AT liuyanan nacetylcysteineandallopurinolsynergisticallyenhancecardiacadiponectincontentandreducemyocardialreperfusioninjuryindiabeticrats
AT ngkwokfj nacetylcysteineandallopurinolsynergisticallyenhancecardiacadiponectincontentandreducemyocardialreperfusioninjuryindiabeticrats
AT xuaimin nacetylcysteineandallopurinolsynergisticallyenhancecardiacadiponectincontentandreducemyocardialreperfusioninjuryindiabeticrats
AT lamkarensl nacetylcysteineandallopurinolsynergisticallyenhancecardiacadiponectincontentandreducemyocardialreperfusioninjuryindiabeticrats
AT irwinmichaelg nacetylcysteineandallopurinolsynergisticallyenhancecardiacadiponectincontentandreducemyocardialreperfusioninjuryindiabeticrats
AT xiazhengyuan nacetylcysteineandallopurinolsynergisticallyenhancecardiacadiponectincontentandreducemyocardialreperfusioninjuryindiabeticrats